SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-23-000043
Filing Date
2023-11-08
Accepted
2023-11-08 07:01:33
Documents
85
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20230930.htm   iXBRL 10-Q 1688022
2 EX-10.1 anip-20230930x10qxexx101.htm EX-10.1 2142831
3 EX-31.1 anip-20230930x10qxexx311.htm EX-31.1 10314
4 EX-31.2 anip-20230930x10qxexx312.htm EX-31.2 9843
5 EX-32.1 anip-20230930x10qxexx321.htm EX-32.1 7033
  Complete submission text file 0001023024-23-000043.txt   11479097

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anip-20230930.xsd EX-101.SCH 57685
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anip-20230930_cal.xml EX-101.CAL 79353
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anip-20230930_def.xml EX-101.DEF 345869
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anip-20230930_lab.xml EX-101.LAB 843841
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anip-20230930_pre.xml EX-101.PRE 555428
79 EXTRACTED XBRL INSTANCE DOCUMENT anip-20230930_htm.xml XML 1308217
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 231385913
SIC: 2834 Pharmaceutical Preparations